Announcements Trials
Browse Landscape

Phase

Phase 1 13Phase 1/2 6Phase 2 4Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 40Lymphoid 33Sarcoma 21Myeloid 21Plasma cell 12Gynecologic 9Dermatologic 9Gastrointestinal 8CNS 8Breast 6Genitourinary 4Classical hematology 4Head & Neck 3Thoracic 2Other neoplasm 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 3Kidney Neoplasms 1Graft vs Host Disease 1Carcinoma, Transitional Cell 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Sirolimus × Genitourinary × Clear all
NCT01856101 2019-04-10

BEZ235

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Terminated
22 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT00378703 2018-11-14

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Completed
361 enrolled 12 charts
Genitourinary

Carcinoma, Renal Cell

NCT00923845 2017-09-29

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
25 enrolled 23 charts
Genitourinary

Carcinoma, Renal Cell, Graft vs Host Disease, Kidney Neoplasms

NCT00353301 2014-04-14

Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma

University of Colorado, Denver

Phase 2 Completed
25 enrolled 9 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡